At the IGTP TODAY
The project, called "Innovation in Tuberculosis - INNOVA4TB", is promoted and coordinated by the research group Innovation in Respiratory Infections and Tuberculosis Diagnosis, led by Dr Jose Domínguez and Dr Cristina Prat. The proposal has received more than a million euros in funding from the 2018 call for Marie Skłodowska-Curie (MSCA) actions
In a recent collaborative work, led by researchers from IDIBELL-ICO (ProCURE, Oncobell programs), IDIAP Jordi Gol and GCAT (Genomes of Life, IGTP), the main diseases and associations that contribute significantly to the appearance of multimorbidity are identified. The study also points out inherited genetic factors that have an influence on the appearance of multimorbidity
The funds collected in the 2017 edition of "La Marathon de TV3" and "Catalunya Ràdio" fundraiser will pay for 36 top-ranked biomedical research projects on infectious diseases with the aim of creating new tools for diagnostics and prevention and more efficient treatments to provide more years of quality life for patients. The 55 researchers who will carry out the research received their certificates today in an event that took place on Tuesday in the Catalan and Balearic Island Academy of Medical Sciences and Health. Two of these projects will be carried out at the Germans Trias i Pujol Research Institute (IGTP) on the Can Ruti Campus.
Pere-Joan Cardona is a physician specialized in microbiology and parasitology and leader of the Experimental Tuberculosis Unit, which has been researching tuberculosis for 20 years at the Germans Trias i Pujol Research Institute (IGTP). Cardona was sworn in as full academician of the Royal European Academy of Doctors (RAED) on Tuesday in a ceremony in the auditorium at Fomento de Trabajo Nacional in Barcelona. Emili Gironella Masgrau made the formal proposal speech.
Researchers have developed a new non-invasive probe to detect the presence of metallic stents and monitor their potential structural failures in models of coronary artery disease. The new probe, which has been successfully tested on a murine model, would enable the substitution of surgical controls in patients with stents with a simple outpatient procedure. The study results from a collaboration between researchers from the Germans Trias i Pujol Research Institute (IGTP), the University of Barcelona (UB) and Universitat Politècnica de Catalunya (UPC).
The second edition of HEALTHIO, a trade fair for health and innovation at the Fira de Barcelona, was held on 16-18 October. It brought together members of the public, health professionals and innovative small companies in an open space designed to promote dialogue between all the players in the healthcare ecosystem and promote evolution of the sector.
Biointaxis, the new spin-off company of the IGTP, was recently constituted. The company stems from research led by Dr Antoni Matilla-Dueñas together with Dr Ivelisse Sánchez of the Neurogenetics Group of the IGTP and has been created to increase translational research leading to treatments and new genomic technologies for rare neurological diseases with genetic causes. The first project the company is undertaking is the development of a gene therapy for Friedreich's Ataxia.
Dr Daniel Fuster of the Addiction Unit of the Internal Medicine Service at the Germans Trias i Pujol University Hospital and Research Institute (IGTP) and the Universitat Autònoma de Barcelona has co-authored a landmark review article on alcohol use in patients with chronic liver disease with Dr Jeffrey H Samet of Boston Medical Center and University School of Medicine. The article has been published in the New England Journal of Medicine.
The Hereditary Cancer Research Group at the IGTP studies the genetic diseases that bring a high risk of developing cancer, one of which is neurofibromatosis (NF). The group has just started two new projects to study neurofibromatosis types 1 and 2 thanks to the support of the Neurofibromatosis Project Foundation.
The IrsiCaixa AIDS Research Institute, the Josep Carreras Leukaemia Research Institute (IJC) and the Germans Trias i Pujol Research Institute (IGTP) have presented the Can Ruti Research Seminar Series 2018-2019. Eleven prestigious speakers from different fields of research will give seminars during the academic year on a range of health research topics of interest to scientists, doctors and students from all the institutions on the campus.
